MedTrace Logo

Study to Assess the Effect of Intrauterine Adminstration of HCG Versus Endometrial Injury by Pipelle

NCT05050747 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 402

Last updated 2025-02-19

No results posted yet for this study

Summary

Our study aims to describe the effect of the intrauterine adminstration of HCG versus the endometrial injury by pipelle on the ongoing pregnancy rate and the biochemical pregnancy rate in women with unexplained infertility undergoing ovulation induction. Also to describe the effect on the first trimester miscarriage rate, ectopic pregnancy rate, and multiple pregnancy.This study is an open-label, prospective, controlled study, multi-center study.

The study participants' relevant medical records will be collected and reviewed after obtaining informed consent for the participants. The study materials that will be used will include blood tests, and ultrasound. The study will involve three study arms.

Conditions

  • Female Infertility

Interventions

DRUG

HCG is introduced at day of trigger intra-uterine

hcg is introduced

DEVICE

endometrial injury by pipelle

endometrial injury using pipelle on day 8-9 on the same cycle of ovulation

Sponsors & Collaborators

  • National Research Centre, Egypt

    collaborator OTHER

  • Wael Elbanna Clinic

    lead OTHER

Eligibility

Min Age
25 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-27
Primary Completion
2024-08-25
Completion
2024-11-12

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05050747 on ClinicalTrials.gov